Education
About Us
Working with TipRanks
Follow Us
HeartFlow, Inc. (HTFL)
NASDAQ:HTFL
HTFL Stock Chart & Stats
$28.78
--
Market closed
$28.78
--
Day’s Range― - ―
52-Week Range$25.38 - $41.22
Previous CloseN/A
VolumeN/A
Average Volume (3M)742.39K
Market Cap
$2.45B
Enterprise Value$2.15B
Total Cash (Recent Filing)$291.17M
Total Debt (Recent Filing)$21.79M
Price to Earnings (P/E)―
Beta2.57
Next Earnings
Feb 12, 2026EPS Estimate
-0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding85,158,720
10 Day Avg. Volume783,181
30 Day Avg. Volume742,389
Financial Highlights & Ratios
PEG Ratio0.81
Price to Book (P/B)-2.11
Price to Sales (P/S)14.41
P/FCF Ratio-24.71
Enterprise Value/Market Cap0.88
Enterprise Value/Revenue16.93
Enterprise Value/Gross Profit22.35
Enterprise Value/Ebitda-45.33
Forecast
1Y Price Target
$38.50Price Target Upside33.77% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)-0.6
Revenue Forecast (FY)$211.77M
Bulls Say, Bears Say
Bulls Say
Clinical Traction And Product InnovationAdoption at academic cardiac CT centers and strong initial reception for PCI Navigator among interventional cardiologists support broader clinical uptake and cross-selling within the coronary artery disease ecosystem.
Commercial CoverageRecent commercial payor wins and expanding coverage permit rapid enablement of plaque scanning in accounts already using HeartFlow's noninvasive physiological assessments.
ReimbursementA high Medicare reimbursement designation for plaque analysis under OPPS beginning in 2026 strengthens payor negotiations and expands access to plaque scanning.
Bears Say
FFRct Reimbursement PressureRevisions to outpatient payment components resulted in lower finalized 2026 reimbursement for FFRct, reducing per-case revenue and pressuring unit economics.
Geographic Access ConstraintsLimited availability of cardiac CT in non-urban markets restricts the addressable market and impedes utilization growth outside major academic centers.
Physician Training BarrierWidespread lack of cardiologist certification to read cardiac CTs limits immediate demand for advanced CT-based services and slows referrals to specialist programs.
HeartFlow, Inc. News
HTFL FAQ
What was HeartFlow, Inc.’s price range in the past 12 months?
HeartFlow, Inc. lowest stock price was $25.38 and its highest was $41.22 in the past 12 months.
What is HeartFlow, Inc.’s market cap?
HeartFlow, Inc.’s market cap is $2.45B.
When is HeartFlow, Inc.’s upcoming earnings report date?
HeartFlow, Inc.’s upcoming earnings report date is Feb 12, 2026 which is in 8 days.
How were HeartFlow, Inc.’s earnings last quarter?
HeartFlow, Inc. released its earnings results on Nov 12, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.242 by -$0.028.
Is HeartFlow, Inc. overvalued?
According to Wall Street analysts HeartFlow, Inc.’s price is currently Undervalued.
Does HeartFlow, Inc. pay dividends?
HeartFlow, Inc. does not currently pay dividends.
What is HeartFlow, Inc.’s EPS estimate?
HeartFlow, Inc.’s EPS estimate is -0.17.
How many shares outstanding does HeartFlow, Inc. have?
HeartFlow, Inc. has 85,158,720 shares outstanding.
What happened to HeartFlow, Inc.’s price movement after its last earnings report?
HeartFlow, Inc. reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.242. Following the earnings report the stock price went down -13.43%.
Which hedge fund is a major shareholder of HeartFlow, Inc.?
Currently, no hedge funds are holding shares in HTFL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HeartFlow, Inc. Stock Smart Score
Company Description
HeartFlow, Inc.
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.
HTFL Earnings Call
Q3 2025
0:00 / 0:00
HTFL Stock 12 Month Forecast
Average Price Target
$38.50
▲(33.77% Upside)
Technical Analysis
Ownership Overview
35.45% Insiders
11.91% Mutual Funds
0.06% Other Institutional Investors
49.63% Public Companies and
Individual Investors